Arcus Biosciences Inc (RCUS)
20.27
+0.45%
Arcus Biosciences Inc (RCUS) is currently trading at $20.27. This represents a gain of 0.45% from the previous session. With a market capitalization of $2.49B, RCUS is a key component of the Health Care sector. Investors looking to trade RCUS should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade RCUS commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Arcus Biosciences Inc (RCUS) shows a bullish trend. Analysts are watching the 20.84 level closely.
Fundamentals
Mkt Cap2.49B
P/E Ratio0.0000
Volume775,521
60-Day Technical Chart
Advanced Charting
Need more indicators for RCUS? Use the world's #1 platform.
Open RCUS on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $20
| Metric |
RCUS +0.45% |
SOFI +3.38% |
BMNR +10.60% |
KVUE -1.37% |
|---|---|---|---|---|
| Price | $20.27 | $19.29 | $21.50 | $18.77 |
| Mkt Cap | $2.49B | $24.60B | $9.78B | $35.98B |
| - | View → | View → | View → |
Latest Headlines
Late-line kidney cancer patients top a year without progression on Arcus drug
Stock Titan • Feb 23, 2026
$RCUS stock is up 16% today. Here's what we see in our data.
Quiver Quantitative • Oct 6, 2025
Why Did Arcus Biosciences Stock Slump 10% Today?
Stocktwits • Dec 12, 2025
Arcus Biosciences (RCUS) Soars 8.5%: Is Further Upside Left in the Stock?
Yahoo Finance • Oct 7, 2025
RCUS Stock Down on Decision to Discontinue GILD Partnered Study
Zacks Investment Research • Dec 15, 2025
● Gemini Agentic AI Analyst Insight for RCUS
Market Education
- How can Retail Traders not lose money to Institutional Traders Jul 15, 2023
- Are Cruise Stocks Finally Back on Course After a Rocky Five Years? Sep 27, 2025
- Canadian ETF Uptrend Pivot Dec 10, 2023
External Research